Children with lower respiratory infections are not beneficiaries of steroidsThe administration of steroid medications may not be useful when it comes to preventing hospitalization or improving respiratory symptoms for treating young children suffering with bronchiolitis, a common viral lower respiratory infection in infants.

The findings by Pediatric Emergency Care Applied Research Network (PECARN) are considered to offer invaluable insights on how to move ahead for treating one of the most common causes of infant hospitalization.

Nathan Kuppermann, M.D., a professor of emergency medicine and pediatrics at the University of California, Davis, chair of the PECARN network’s steering committee, and the senior investigator of the study, remarked that this study suggested the effectiveness of a research network such as PECARN for resolving difficult-to-answer questions.